Angiodynamics (ANGO) Assets (2011 - 2026)

Angiodynamics (ANGO) has reported Assets for 16 consecutive years, with $267.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets fell 4.63% year-over-year to $267.2 million; the trailing twelve-month figure through May 2026 stood at $267.2 million (down 4.63% YoY), and the FY2026 full-year result was $267.2 million, down 4.63% from the prior year.
• Assets advanced to $267.2 million in Q2 2026 per ANGO's latest filing, from $260.7 million in the prior quarter.
• Across five years, Assets topped out at $558.2 million in Q4 2022 and bottomed at $260.7 million in Q1 2026.
• Historically, Assets has averaged $396.5 million across 5 years, with a median of $321.3 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Assets climbed 0.74% in 2022, then slumped 41.64% in 2024.
• Over 5 years, Assets stood at $558.2 million in 2022, then slipped by 10.5% to $499.6 million in 2023, then plunged by 41.64% to $291.6 million in 2024, then dropped by 7.52% to $269.7 million in 2025, then decreased by 0.93% to $267.2 million in 2026.
• According to Business Quant data, Assets over the past three periods registered $267.2 million, $260.7 million, and $269.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.